This technology is a modified bacterial model for improved expression and production of proteins.
Commonly used models for protein expression and production include models derived from bacteria, yeast, and mammalian cells. Escherichia coli is a popular model due to its fast growth kinetics, easy cell culture, and fast and easy transformation with exogenous DNA. However, these expression models often result in low protein yields of unstable proteins.
This technology is a modified bacterial model for expression and production of protein. By modifying the BL21(DE3) model, it has an improved yield and can produce unstable proteins. By increasing the production yield, this technology has the potential to increase efficiency in protein production projects.
Patent Issued(US10,745,730)
Patent Issued(US11,624,081)
IR CU15233, CU15280
Licensing Contact: Joan Martinez